The global gold nanoparticles market revenue was USD 6,641.1 million in 2022 to grow at a compound annual growth rate (CAGR) of 22.3% from 2023 to 2030. Increasing use of metal nanoparticles in medical and dentistry, particularly in target imaging and diagnostics, is majorly driving the market growth. The rising scope of application in medical imaging due to intrinsic properties is also expected to positively influence growth. Metal nanoparticles possess exceptional properties, such as great absorption with less interference of bone and tissue, high scattering ability, and strong optoacoustic signals for applications in the medical sector. Nanoparticles are also being widely accepted in targeted cancer imaging and therapy owing to selective accumulation in tumor cells and high biocompatibility.
The growing diagnostics industry in North America is expected to lead the regional market. High demand for nanotech products in medical diagnostics coupled with rising demand for metal nanoparticles in tumor detection and improved drug delivery systems is also expected to positively impact the regional demand for gold nanoparticles over the forecast period.
Moreover, rising spending on R&D activities and innovations in nanoparticle technology is also expected to propel the North American market. The rise in disposable income of consumers and their inclinations towards improved medical treatment and rising awareness for quick diagnosis and fast recovery are also contributing to the gold nanoparticles market growth in the region.
Extensive R&D in gold nanotechnology has increased its scope of application in glass technology, pharmaceuticals, photometry, and electronics, among others. Nanoparticles made out of gold and silver are used to alter and improve the pharmacodynamic and pharmacokinetic properties of different drug molecules. Besides, an increasing demand from the electronics industry and gold uses for niche applications like gold nanowires (biosensors) are also driving the market. Nonetheless, strict regulations by regional or national government authorities for the use of nanomaterials in different products due to health, environmental, and safety issues are affecting the market growth.
The medical and dentistry segment was valued at USD 3.51 billion in 2022 and is expected to expand at a significant CAGR by 2030 due to the growing application of nanomaterials in medical imaging, therapeutics, and diagnostics. Moreover, increasing funding for R&D for drug delivery systems and cancer-targeting nanoparticle technology is also driving the growth.
The high demand for nanotechnology-based therapeutics and diagnostics in the medical industry is augmenting the demand for gold nanoparticles. Improvements in medical imaging and nanomedicines drive the demand for quality and superior products. Additionally, the growing awareness of metal nanoparticles is also expected to fuel the market in near the near future
The electronics segment is predicted to expand at the fastest CAGR of 23.7% during the forecast period owing to the high demand for compact storage devices and increasing the use of nanotechnology in photovoltaic cells. Furthermore, increasing the use of nanomaterials in nanowires for biosensors is also driving the segment.
Nanoparticle printing inks are widely used in USB drives, CDs, DVDs, and internet dongles. Gold nanoparticle inks are also used in photovoltaic cells, photo-sensors and detectors, and thin-film transistors. Moreover, the growing application scope in photovoltaic cells is also expected to drive the market over the forecast period.
Enhancements in catalytic technology, along with growing demand for ‘green label’ catalysts with better selectivity and activity, are driving the market in North America. Furthermore, huge R&D investments by individual nanotechnology organizations and universities are expected to propel regional demand in the forthcoming years.
Increasing supportive initiatives by the government of emerging economies like China and India to facilitate FDI flow in the chemical domain positively impacts market growth. Moreover, an increasing awareness and acceptance of gold nanoparticle catalysts over traditional metals, such as palladium and platinum, is also contributing significantly to the market.
North America was estimated at USD 2.05 billion in 2022 and is expected to expand at a healthy CAGR of over 21.2% by 2030 due to the presence of a well-established healthcare sector in the region. Additionally, growing investments in R&D activities are expected to boost the market in the forthcoming years. Researchers are introducing products that can attract and destroy viruses in the human body. These products will imitate human body cells and cure antimicrobial diseases. Various materials are being introduced for treating skin aging diseases, which is benefitting the medical sector, thereby driving the regional growth.
Europe is predicted to expand at a CAGR of 18.5% in terms of revenue by 2030, owing to an increase in healthcare spending and innovations in in-vitro therapeutics and diagnostics. Moreover, potential demand from Europe due to the growing medical and healthcare domain is expected to contribute to regional growth.
Increasing the application scope of nanoparticles in the making of glass tinting, photovoltaic plates, and fruit protection is an opportunity for the market players. Furthermore, growing niche applications, such as nanowires, fruit, and vegetable protection, will also create huge opportunities for the market in the near future.
The market for gold nanoparticles is highly competitive owing to the fragmented nature of the market. These players are significantly investing in research and development to expand the product's application scope. Moreover, they are also focusing on strategies such as mergers and acquisitions, capacity expansion, and maintaining a strong relationship with local and regional distributors to increase their market share. Some prominent players in the gold nanoparticles market include:
Solaris Nanosciences Corporation
Tanaka Holdings Co. Ltd.
The Metalor Group
Market size value in 2023
USD 7.57 billion
Revenue forecast in 2030
USD 15.65 billion
CAGR of 22.3% from 2023 to 2030
Base year for estimation
Actual estimates/Historical data
2018 - 2021
2023 - 2030
Volume in kilotons and revenue in USD million and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Russia; Spain; Australia; South Korea; China; India; Japan; Brazil; Argentina
Key companies profiled
Cytodiagnostics Inc.; Goldsol Inc; BBI Solutions; NanoHybrids Inc.; Nanopartz Inc.; Nanosphere Inc.; Nanostellar Inc.; Solaris Nanosciences Corporation; Tanaka Holdings Co. Ltd.; The Metalor Group; Sigma Aldrich
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global gold nanoparticles market report based on end-use and region:
End-use Outlook (Volume, Kilo Grams; Revenue, USD Million; 2018 - 2030)
Medical & Dentistry
Regional Outlook (Volume, Kilo Grams; Revenue; Revenue, USD Million; 2018 - 2030)
Central & South America
Middle East & Africa
b. The global gold nanoparticles market size was estimated at USD 6,641.1 million in 2022 and is expected to reach USD 7,570.9 million in 2023.
b. The gold nanoparticles market is expected to grow at a compound annual growth rate of 22.3% from 2023 to 2030 to reach USD 15.65 billion by 2030.
b. Medical and dentistry dominated the gold nanoparticles market with a share of 52.4% in 2022, on account of growing application of nanomaterials in medical imaging, therapeutics, and diagnostics.
b. Some of the key players operating in the gold nanoparticles market include Cytodiagnostics Inc., Goldsol Inc, BBI Solutions, NanoHybrids Inc., Nanopartz Inc., Nanosphere Inc., Nanostellar Inc., Solaris Nanosciences Corporation, Tanaka Holdings Co. Ltd., The Metalor Group, Sigma Aldrich
b. The key factors that are driving the gold nanoparticles market include increasing the use of metal nanoparticles in medical and dentistry, particularly in target imaging and diagnostics.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."